Lenalidomide and High-Dose Melphalan

Clinical trial NCT01079936 · COMPLETED

Trial details

NCT number: NCT01079936
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Myeloma Stem Cell Transplantation

Start date: 2010-03-01
Primary completion: 2015-03-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.